vs

Side-by-side financial comparison of BARNWELL INDUSTRIES INC (BRN) and Arcadia Biosciences, Inc. (RKDA). Click either name above to swap in a different company.

BARNWELL INDUSTRIES INC is the larger business by last-quarter revenue ($3.0M vs $901.0K, roughly 3.3× Arcadia Biosciences, Inc.). BARNWELL INDUSTRIES INC runs the higher net margin — -80.9% vs -148.3%, a 67.4% gap on every dollar of revenue. On growth, BARNWELL INDUSTRIES INC posted the faster year-over-year revenue change (9.7% vs -25.8%). Over the past eight quarters, Arcadia Biosciences, Inc.'s revenue compounded faster (-4.5% CAGR vs -30.2%).

Evening Post Industries is a privately held American media company based in Charleston, South Carolina, United States. It has been led by four generations of the Manigault family.

Arcadia Biosciences is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity. The company is partly owned by Moral Compass Corporation.

BRN vs RKDA — Head-to-Head

Bigger by revenue
BRN
BRN
3.3× larger
BRN
$3.0M
$901.0K
RKDA
Growing faster (revenue YoY)
BRN
BRN
+35.6% gap
BRN
9.7%
-25.8%
RKDA
Higher net margin
BRN
BRN
67.4% more per $
BRN
-80.9%
-148.3%
RKDA
Faster 2-yr revenue CAGR
RKDA
RKDA
Annualised
RKDA
-4.5%
-30.2%
BRN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BRN
BRN
RKDA
RKDA
Revenue
$3.0M
$901.0K
Net Profit
$-2.4M
$-1.3M
Gross Margin
21.4%
Operating Margin
-23.0%
-152.8%
Net Margin
-80.9%
-148.3%
Revenue YoY
9.7%
-25.8%
Net Profit YoY
-29.0%
67.1%
EPS (diluted)
$-0.25
$-0.97

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BRN
BRN
RKDA
RKDA
Q4 25
$901.0K
Q3 25
$3.0M
$1.3M
Q2 25
$3.2M
$1.5M
Q1 25
$3.6M
$1.2M
Q4 24
$3.9M
$1.2M
Q3 24
$2.7M
$1.5M
Q2 24
$4.5M
$1.3M
Q1 24
$4.7M
$987.0K
Net Profit
BRN
BRN
RKDA
RKDA
Q4 25
$-1.3M
Q3 25
$-2.4M
$856.0K
Q2 25
$-1.6M
$-4.5M
Q1 25
$-1.2M
$2.6M
Q4 24
$-1.9M
$-4.1M
Q3 24
$-1.9M
$-1.6M
Q2 24
$-1.2M
$1.1M
Q1 24
$-1.8M
$-2.4M
Gross Margin
BRN
BRN
RKDA
RKDA
Q4 25
21.4%
Q3 25
32.1%
Q2 25
43.4%
Q1 25
43.2%
Q4 24
31.9%
Q3 24
32.9%
Q2 24
51.5%
Q1 24
52.3%
Operating Margin
BRN
BRN
RKDA
RKDA
Q4 25
-152.8%
Q3 25
-23.0%
-88.5%
Q2 25
1.6%
-34.4%
Q1 25
21.7%
44.2%
Q4 24
-2.7%
-187.7%
Q3 24
-1.3%
-114.5%
Q2 24
7.9%
Q1 24
-14.7%
-160.9%
Net Margin
BRN
BRN
RKDA
RKDA
Q4 25
-148.3%
Q3 25
-80.9%
65.7%
Q2 25
-48.6%
-306.4%
Q1 25
-33.8%
216.6%
Q4 24
-48.7%
-334.5%
Q3 24
-68.8%
-104.9%
Q2 24
-27.7%
81.2%
Q1 24
-37.9%
-245.5%
EPS (diluted)
BRN
BRN
RKDA
RKDA
Q4 25
$-0.97
Q3 25
$-0.25
$0.62
Q2 25
$-0.15
$-3.26
Q1 25
$-0.12
$1.90
Q4 24
$-0.19
$-2.99
Q3 24
$-0.19
$-1.18
Q2 24
$-0.12
$0.78
Q1 24
$-0.18
$-1.78

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BRN
BRN
RKDA
RKDA
Cash + ST InvestmentsLiquidity on hand
$2.9M
$4.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$7.0M
$4.1M
Total Assets
$20.8M
$6.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BRN
BRN
RKDA
RKDA
Q4 25
$4.6M
Q3 25
$2.9M
$5.9M
Q2 25
$1.2M
$4.4M
Q1 25
$1.4M
$3.2M
Q4 24
$2.0M
$4.2M
Q3 24
$4.3M
$6.6M
Q2 24
$4.4M
$8.1M
Q1 24
$3.7M
$8.5M
Stockholders' Equity
BRN
BRN
RKDA
RKDA
Q4 25
$4.1M
Q3 25
$7.0M
$5.4M
Q2 25
$8.6M
$4.5M
Q1 25
$10.1M
$8.9M
Q4 24
$11.3M
$6.2M
Q3 24
$13.0M
$10.3M
Q2 24
$15.0M
$11.7M
Q1 24
$16.4M
$10.6M
Total Assets
BRN
BRN
RKDA
RKDA
Q4 25
$6.5M
Q3 25
$20.8M
$8.6M
Q2 25
$23.8M
$7.8M
Q1 25
$24.4M
$13.0M
Q4 24
$26.0M
$13.5M
Q3 24
$30.7M
$15.2M
Q2 24
$31.4M
$17.4M
Q1 24
$32.8M
$16.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BRN
BRN
RKDA
RKDA
Operating Cash FlowLast quarter
$-610.0K
$-861.0K
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BRN
BRN
RKDA
RKDA
Q4 25
$-861.0K
Q3 25
$-610.0K
$-257.0K
Q2 25
$-309.0K
$-2.0M
Q1 25
$-302.0K
$-1.6M
Q4 24
$-759.0K
$-2.2M
Q3 24
$1.2M
$-1.8M
Q2 24
$1.3M
$-2.5M
Q1 24
$887.0K
$-3.2M
Free Cash Flow
BRN
BRN
RKDA
RKDA
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$-3.3M
Q3 24
Q2 24
$-2.5M
Q1 24
$-3.2M
FCF Margin
BRN
BRN
RKDA
RKDA
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-83.6%
Q3 24
Q2 24
-188.3%
Q1 24
-326.5%
Capex Intensity
BRN
BRN
RKDA
RKDA
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.0%
Q4 24
64.3%
0.0%
Q3 24
0.0%
Q2 24
0.2%
Q1 24
1.3%
Cash Conversion
BRN
BRN
RKDA
RKDA
Q4 25
Q3 25
-0.30×
Q2 25
Q1 25
-0.61×
Q4 24
Q3 24
Q2 24
-2.31×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons